Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. medmico

MEDMICO

Moving to Efficient Diabetes care: Multimode Integrated CO-morbidity diagnostics platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MEDMICO project word cloud

Explore the words cloud of the MEDMICO project. It provides you a very rough idea of what is the project "MEDMICO" about.

laboratories    cardiovascular    clinical    pilot    12    validated    primary    precision    projections    innovation    trinity    lab    3    disruptive    temperature    patients    turbidimetry    diagnose    diabetic    extensive    college    life    near    care    patient    launch    integrating    radisens    healthcare    shelf    quad    validation    optimal    kidney    morbid    screen    date    storage    monitor    panels    clinics    forefront    2013    dublin    rising    heart    away    hba1c    mode    co    evidenced    complications    epidemic    contractor    shift    gt    submission    trials    diagnostic    outpatient    outcomes    room    2035    sub    population    incorporates    drive    creatinine    central    single    renal    delivering    segments    cell    efficient    vitro    breakthrough    sensitivity    5    trl8    workflow    abnormalities    1st    comorbid    usability    combat    efficiencies    chemistry    counting    medmico    diagnostics    disease    multiple    immunoassays    platform    diabetes    incumbent    poct    spearhead    tests    pipette    accuracy    comorbidities    months    majority    revenues    ready    ischemic    comorbidity    expertise    provides    point    biomaterials    prototype    regulatory    adult    lipids    positioning    pharmacies   

Project "MEDMICO" data sheet

The following table provides information about the project.

Coordinator		 RADISENS DIAGNOSTICS LIMITED 

Organization address
address: UNITS 1-3 WESTPOINT BUILDINGS LINK ROAD BALLINCOLL
city: CORK
postcode: IP31 HF29
website: www.radisens.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://www.radisens.com/
 Total cost 4˙487˙525 €
 EC max contribution 4˙487˙525 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RADISENS DIAGNOSTICS LIMITED IE (CORK) coordinator 4˙487˙525.00

Map

 Project objective

Diabetes affects 8.5% (2013) of the adult European population rising to 10.3% (2035) and is associated with co-morbid conditions such as cardiovascular and renal abnormalities. These lead to diabetic complications, ischemic heart disease, heart failure and kidney failure. Management of this growing epidemic requires a shift in care management and delivery, away from lab testing. The majority of current diagnostic testing for diabetes and comorbidities involves central laboratories as incumbent in-vitro diagnostic point-of-care testing (PoCT) provides sub-optimal accuracy and single tests (rather than needed panels) for diabetes and its comorbidities. MEDMICO will spearhead a diagnostic breakthrough by delivering the 1st quad-mode PoCT platform integrating immunoassays, turbidimetry, clinical chemistry and cell counting. HbA1c, Lipids and Creatinine tests will be integrated on to a single diabetes comorbid platform with state-of-the-art sensitivity/precision, room temperature storage, >12 months’ shelf-life and integrated pipette to screen, diagnose and monitor patients, within primary care, outpatient clinics and pharmacies. This will improve patient outcomes and healthcare efficiencies, positioning Europe at the forefront of healthcare innovation and deliver an efficient platform to combat this epidemic. MEDMICO incorporates extensive technical, clinical and exploitation expertise - Radisens’ disruptive PoCT prototype and Trinity College Dublin (sub-contractor) biomaterials expertise and diabetes patient access. MEDMICO’s potential is evidenced by Radisens’ revenues to date and large near-term projections from diagnostics partners before its launch. Existing research of end-user needs and workflow assessment will drive platform development and pilot production, with clinical validation and usability trials in multiple PoCT segments to TRL8. This will deliver a validated quad-mode diabetes comorbidity platform, ready for regulatory submission.

 Deliverables

List of deliverables.
Target stakeholder web site & project presentation Websites, patent fillings, videos etc. 2019-07-24 15:31:59

Take a look to the deliverables list in detail:  detailed list of MEDMICO deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDMICO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDMICO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More